Since you picked on the topic which I've posted over and over. Number one issue cash on hand, selling ATM = dilution too especially with such low volume.
Although MNK was predicted to launch May 1 back then, I don't see that happening based on experience. I predicted delays and that does not help with problem number one cash on hand = potentially more selling in ATM.
You saw it with your own eyes, IPCI said cash enough till June, then changed to July, and now it's enough till September. That's telling you they are also expecting delays in revenue and they are either cutting back on spending or selling more ATM. No body can be certain things won't go wrong and IPCI ended up running out of money before new revenue comes in. They are cutting it too close and investors don't like that.
Rexista law suit, nobody can be certain how long the delay would be or if any deals can be made prior to approval like Odidi suggested they would partner prior to approval come September.
Lastly, a picture is worth a thousand word. Take a look at the chart!
Why am I getting back in now? Simple, IPCI indicated they shipped Seroquel. FDA gave the final green light. The MNK selling generic business news was unexpected, but we knew that's not happening any time soon even if they were planning on selling their generic business. I am not the only person who was worried about this for a second. I feel some of the risk are removed and it doesn't looks like we drop lower than current level. I went in again at 1.92, and I am glad we are actually green today!
News 
Market Data 
Discover 
AI
